Nominations open for 2023 GSK Award for Research Excellence

Nominations for the 2023 GSK Award for Research Excellence (ARE) — one of the most prestigious and longstanding awards available to the Australian medical research community — are now open.

Since 1980, the annual GSK ARE has been awarded to individuals or two-person teams with very significant existing track records who are well placed to further their contributions in the near future. A $100,000 grant to the winner’s institution supports this goal.

Previous recipients of the GSK ARE include some of Australia’s most noted scientific researchers, including Professor Tony Basten (1980), Dr Bruce Kemp (1993), Professor Kathryn North (2011) and Professors Georgina Long and Richard Scolyer (2018). Last year’s award was won by Professor Georgia Chenevix-Trench, a Distinguished Scientist at the QIMR Berghofer Medical Research Institute, in recognition of her research investigating genetic predispositions to breast and ovarian cancer. Her research has elevated global understanding of why some people have a genetic risk of cancer and what determines it, and has also contributed to the development of better screening, possible prevention solutions and treatment options for patients.

The 2023 GSK Award for Research Excellence will be presented at the Research Australia Health and Medical Research Awards. The judging criteria are weighted as follows:

• 50% — potential for the nominee’s contribution to science to directly or indirectly lead to the improvement of human health;
• 30% — potential for the nominee to continue to make research contributions in the field of human health;
• 20% — nominee’s accomplishments based on academic and employment record, research grants and awards received, cited publications, and other examples of research productivity.
   

To submit a nomination, please complete the 2023 GSK ARE Nomination Form. Nominations close on 16 June and any queries can be sent to are.arenominations@gsk.com.

Image credit: iStock.com/olegback